![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics, Inc. Reports Fourth Quarter and Year End 2010 Financial Results
March 28, 2011 09:00 ET
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., March 28, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) today reported financial results for the fourth quarter and full year ended December 31, 2010, and provided...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics to Host a Conference Call to Report Fourth Quarter and Full Year 2010 Results and Business Update on March 28, 2011
March 24, 2011 19:49 ET
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., March 24, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Monday, March 28, 2011 at 8am PT, to include a discussion of results and...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics to Present at the Roth Capital Partners 23rd Annual OC Growth Stock Conference
March 14, 2011 08:30 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 14, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics (OTCBB:TLON), announced that Steven R. Deitcher, M.D., President and Chief Executive Officer, is scheduled to present...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
New Patent Issued for Talon Therapeutics' Marqibo(R) Expands Disease Coverage to Include Lymphoma, Leukemia and Myeloma
March 10, 2011 08:30 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 10, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON), today announced the issuance of U.S. patent 7,887,836 B2, which covers compositions and methods...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences to Change Name to Talon Therapeutics
December 01, 2010 08:30 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 1, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, announced that its...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences to Present Data on Marqibo(R) at the 2010 American Society of Hematology Annual Meeting and Exposition
November 29, 2010 09:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 29, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Reports Third Quarter 2010 Financial Results
November 12, 2010 09:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences, Inc. (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences to Host a Conference Call to Report Third Quarter 2010 Results and Business Update on November 12, 2010
November 08, 2010 17:23 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 8, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences, Inc. (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, will host a...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Reverse Stock Split Effective Monday, September 13, 2010
September 10, 2010 16:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences, Inc. (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Reports Second Quarter 2010 Financial Results
August 13, 2010 06:15 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 13, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences Inc. (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported...